Ascend Wellness Holdings, Inc. (CSE: AAWH.U), a vertically integrated multi-state cannabis operator, reported third-quarter 2026 net revenue of $130.0 million, up 4.2% year-over-year and 3.1% sequentially. The company generated Adjusted EBITDA of $31.1 million and positive operating cash flow of $5.4 million despite a $19.1 million semi-annual interest payment. Notably, AWH has since surpassed its year-end target of 60 retail locations, now operating 61 stores, a milestone investors may be watching closely as the company pursues further retail densification.

Key Points

  • Ascend Wellness Holdings, Inc. (CSE: AAWH.U; OTCQX: AAWH)
  • Q3 2026 net revenue reached $130.0 million, with retail revenue rising 5.5% sequentially to $97.8 million
  • Adjusted EBITDA of $31.1 million; Adjusted EBITDA Margin of 23.9%; cash and equivalents of $63.6 million as of September 30, 2026
  • Investors may be watching the company's Q4 2026 guidance of 1–2% revenue growth and consistency in Adjusted EBITDA Margin with Q3

Retail Expansion and Record Transaction Volume Drive AWH's Q3 Performance

AWH ended Q3 2026 with 56 retail stores and has since grown to 61 locations, exceeding its year-end target ahead of schedule. Total retail transactions reached approximately 1.7 million in the quarter, described in the release as the most of any quarter in the company's history, representing a 6.0% sequential and 14.9% year-over-year increase. New Jersey locations showed particularly strong momentum, with transactions up 18% sequentially and 37% year-over-year. Retail revenue represented 75.2% of total net revenue, up from 73.5% in Q2 2026, reflecting the company's deliberate shift toward higher-margin retail channels.

AWH's Brand Position and Canadian Licensing Agreement Mark Strategic Milestones

AWH maintained its position as the number two brand house by both sales and units across its core markets of Illinois, New Jersey, and Massachusetts combined, according to BDSA. Its Ozone brand held the number three position in dollar share and number one in units across those markets. The company also entered a capital-light brand licensing agreement with Atlantic Cultivation, a Canadian craft cannabis producer, with select Ozone and High Wired products expected to reach Canadian shelves in the first quarter of 2027, representing AWH's first market outside the United States.

Mortgage Financing and Reverse Stock Split Approval Support AWH's Capital Strategy

AWH closed $11 million in non-dilutive mortgage loans with CF Bank, secured by five company-owned properties in Illinois, Maryland, and Massachusetts, carrying an 8.5% annual interest rate and maturing in October 2031. The company stated it intends to use the proceeds to support retail expansion and acquisition opportunities. Stockholders also approved a reverse stock split of the company's Class A common shares at a special meeting on August 28, 2026, giving the board flexibility on ratio and timing. AWH stated it intends to use the split to support a potential listing on a major U.S. exchange, subject to regulatory developments including broader cannabis rescheduling.

Q4 2026 Outlook and Full-Year Capital Expenditure Guidance

For Q4 2026, AWH anticipates a 1 to 2% increase in revenue, with Adjusted EBITDA Margin expected to be consistent with Q3 2026 levels. Full-year 2026 capital expenditures are expected to be approximately $20 million, with $15.7 million spent year-to-date through September 30. Free Cash Flow for Q3 2026 was $2.7 million. Net Debt as of September 30, 2026 stood at $260.4 million, while the net loss for Q3 2026 was $28.0 million, widening from $9.8 million in Q2 2026, which had included a one-time tax benefit of $14.8 million.